Drug Profile
Research programme: non-steroidal anti-inflammatory drugs - Angelini Pharmaceuticals
Alternative Names: Nsaids new formulations - AngeliniLatest Information Update: 28 Aug 2020
Price :
$50
*
At a glance
- Originator Angelini Pharmaceuticals
- Class Analgesics; Nonsteroidal anti-inflammatories
- Mechanism of Action Cyclooxygenase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Inflammation; Pain
Most Recent Events
- 28 Aug 2020 No recent reports of development identified for preclinical development in Inflammation in Italy
- 28 Aug 2020 No recent reports of development identified for preclinical development in Pain in Italy
- 15 Jul 2016 Preclinical trials in Inflammation in Italy (unspecified route)